In light of the recent adjustment to the constituent stocks of the Hang Seng Composite SmallCap Index, the Shenzhen Stock Exchange has announced that the list of eligible securities for Hong Kong Stock Connect will undergo a revision, effective from July 30, 2025. Notably, Tongyang Changjiang Pharmaceutical has been removed from this list.
